Iontophoretic delivery device

• US 5,147,297 A
• Filed: 05/07/1990
• Issued: 09/15/1992
• Est. Priority Date: 05/07/1990
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Stahl, Mark G., Myers, Robert M.
• Primary Examiner(s): Pellegrino, Stephen C.
• Assistant Examiner(s): Rafa, Michael
• Application Number:
  US07/521,761
• Time in Patent Office: 862 Days
• Field of Search: 604/20, 128/798, 128/802, 128/803, 128/898
• US Class Current: 604/20
• CPC Class Codes: A61N 1/0448 Drug reservoir
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Abstract

An electrically powered iontophoretic delivery device is provided. The device utilizes electrodes composed of a polymeric matrix containing about 5 to 40 vol % of a conductive filler which forms a conductive network through the matrix, and about 5 to 40 vol % of a chemical species which is able to undergo either oxidation or reduction during operation of the device. Preferably, the conductive filler is carbon or graphite fibers. For the anode electrode, the chemical species should be able to undergo oxidation and is preferably either silver or zinc. For the cathode electrode, the chemical species should be able to undergo reduction and is preferably silver chloride.

Claims

1. An electrically powered iontophoretic delivery device including a donor electrode assembly, a counter electrode assembly and a source of electrical power adapted to be electrically connected to the donor electrode assembly and the counter electrode assembly, at least one of the electrode assemblies including an agent reservoir containing an agent, the agent reservoir adapted to be placed in agent transmitting relation with a body surface, and an electrode adapted to be electrically connected to the source of electrical power and to the agent reservoir, wherein the electrode comprises:

a polymeric matrix;

about 5 to 40% of a conductive filler forming a conductive network through the matrix; and

about 5 to 40 vol% of a chemical species able to undergo oxidation or reduction during operation of the device, the matrix having a plurality of fluid flow pathways therethrough.

2. The device of claim 1, wherein the electrode is an anode and the chemical species is a metal able to undergo oxidation during operation of the device.

3. The device of claim 2, wherein the metal is selected from the group consisting of silver and zinc.

4. The device of claim 1, wherein the electrode is a cathode and the chemical species is able to undergo reduction during operation of the device.

5. The device of claim 4, wherein the chemical species able to undergo reduction is selected from the group consisting of AgCl, AgBr, and Ag₄ Fe(CN)₆.

6. The device of claim 1, wherein the conductive filler comprises carbon fibers.

7. The device of claim 1, wherein the polymer comprises a hydrophobic polymer.

8. The device of claim 7, wherein the hydrophobic polymer is selected from the group consisting of ethylene vinyl acetate copolymers, polyalkylenes, polyisoprenes, rubbers, polyvinylacetate, polyamides, polyurethanes, polyvinylchlorides, and modified cellulosic polymers.

9. The device of claim 1, wherein the matrix is in the form of a film.

10. The device of claim 9, wherein the conductive filler comprises carbon fibers, the carbon fibers forming an unoriented conductive carbon fiber network within the film.

11. The device of claim 1, wherein the fluid flow pathways are comprised of a pore forming agent in the polymeric matrix.

12. The device of claim 1, wherein the counter electrode assembly includes a counter electrode adapted to be electrically connected to the source of electrical power and an electrolyte reservoir adapted to be placed in electrolyte transmitting relation with the body surface the counter electrode being in electrical contact with the electrolyte reservoir;

wherein the counter electrode comprises;

a polymeric matrix;

about 5 to 40 vol% of a conductive filler forming a conductive network through the matrix; and

about 5 to 40 vol% of a chemical species able to undergo oxidation or reduction during operation of the device.

13. The device of claim 12, wherein the electrolyte reservoir is a polymeric matrix comprised of about 10 to 60 wt% of a hydrophilic polymer about 10 to 60 wt% of a hydrophobic polymer and up to about 50 wt% of the electrolyte.

14. The device of claim 1, wherein the donor electrode assembly includes a donor electrode adapted to be electrically connected to the source of electrical power and a drug reservoir adapted to be placed in drug transmitting relation with the body surface the donor electrode having a surface which is in contact with the drug reservoir.

15. The device of claim 14, wherein the drug reservoir is a polymeric matrix comprised of about 10 to 60 wt% of a hydrophilic polymer, about 10 to 60 wt% of a hydrophobic polymer and up to about 50 wt% of the drug.

16. The device of claim 1, wherein the power source comprises a battery.

17. The device of claim 1, wherein the agent comprises a drug.

18. The device of claim 17, wherein the drug is a water soluble drug salt.

19. The device of claim 1, wherein the agent comprises an electrolyte.

20. The device of claim 19, wherein the electrolyte comprises a water soluble electrolyte salt.

21. The device of claim 12, wherein a plurality of fluid flow pathways are provided through the counter electrode.

22. The device of claim 21, wherein the fluid flow pathways are comprised of a pore forming agent in the polymeric matrix.

23. The device of claim 11 or 22, wherein the matrix contains about 10 to 50 vol% of the pore forming agent.

24. The device of claim 11 or 22, wherein the matrix contains about 20 to 35 vol% of the pore forming agent.

25. The device of claim 11 or 22, wherein the pore forming agent is selected from the group consisting of pore forming solids and pore forming liquids.

26. The device of claim 11 or 22, wherein the pore forming agent comprises a material which sorbs water.

27. The device of claim 11 or 22, wherein the pore forming agent comprises a material which is dissolved, extracted or leached by water.

28. The device of claim 11 or 22, wherein the pore forming agent comprises a polymer which sorbs water.

29. The device of claim 28, wherein the pore forming agent is a polymer which is water soluble.

30. The device of claim 29, wherein the pore forming agent is a polymer which is water swellable.

31. The device of claim 11 or 22, wherein the pore forming agent comprises a salt.

32. The device of claim 11 or 22, wherein the pore forming agent is a polymer selected from the group consisting of starch-graft poly (Na-acrylate co-acrylamide) polymers and polyethylene oxides.

33. The device of claim 11 or 22, wherein the pore forming agent comprises a polysaccharide.

34. A method of activating a non-hydrated electrode assembly in an electrically powered iontophoretic delivery device, the device including a donor electrode assembly, a counter electrode assembly and a source of electrical power adapted to be electrically connected to the donor electrode assembly and the counter electrode assembly, at least one of the electrode assemblies including a non-hydrated agent reservoir containing an agent and an electrode, comprising:

electrically connecting the electrode, which electrode is comprised of a polymeric matrix, about 5 to 40 vol% of a conductive filler forming a conductive network through the matrix and about 5 to 40 vol% of a chemical species able to undergo oxidation or reduction during operation of the device, to the source of electrical power and to the agent reservoir;

forming a plurality of fluid flow pathways through the polymer matrix of the electrode;

delivering a liquid solvent through the plurality of fluid flow pathways into the non-hydrated agent reservoir; and

placing the agent reservoir in agent transmitting relation with a body surface.

35. The method of claim 34, wherein the step of forming the plurality of fluid flow pathways comprises mixing a pore forming agent into the polymer matrix.

36. The method of claim 34, wherein the fluid flow pathways are formed by punching the pathways through the electrode.

37. The method of claim 34, wherein the fluid flow pathways are formed by molding the pathways through the electrode.

38. The method of claim 35, wherein the pore forming agent is selected from the group consisting of pore forming solids and pore forming liquids.

39. The method of claim 35, wherein the pore forming agent sorbs water.

40. The method of claim 35, wherein the pore forming agent is dissolved, extracted or leached by water.

41. The method of claim 35, wherein the pore forming agent comprises a polymer which sorbs water.

42. The method of claim 35, wherein the pore forming agent is a polymer which is water soluble.

43. The method of claim 35, wherein the pore forming agent is a polymer which is water swellable.

44. The method of claim 35, wherein the pore forming agent comprises a salt.

45. The method of claim 35, wherein the pore forming agent is a polymer selected from the group consisting of starch-graft poly (Na-acrylate co-acrylamide) polymers and polyethylene oxides.

46. The method of claim 35, wherein the pore forming agent comprises a polysaccharide.